Tradestie Institutional Equity Comparison Engine

FEMY vs BLFS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BLFS Overall Edge

BLFS Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioLife Solutions Inc. (BLFS) driven by superior Valuation, Growth & Margin, Options & Structure while FEMY counters with relative strength in Momentum & Technical. Fundamentally, FEMY trades at N/M Forward P/E with -763.9% operating margin (-18.9% YoY revenue) versus BLFS at 117.0x Forward P/E and 6.0% operating margin (+21.5% YoY). In options structure, FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BLFS sits in BREAKOUT (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner BLFS
FEMY N/M vs BLFS 117.0x Fwd P/E
Growth & Margin Winner BLFS
Op Margin -763.9% vs 6.0% ยท YoY -18.9% vs +21.5%
Momentum & Technical Winner FEMY
1Y +54.8% vs +49.0% ยท 52W Pos 17% vs 95%
Options & Structure Winner BLFS
UNCLASSIFIED (N/A IV) vs BREAKOUT (6th %ile IV)
FEMY NASDAQ
Femasys Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.28
-9.86% 1D
Market Cap $11.9M
1M Return -22.42%
1Y Return +54.78%
Forward P/E N/M
Unified AI Score
52.6 / 100 HOLD
Tech 61.0 Fund 62.0 Flow 50.0 Mom 64.0
BLFS NASDAQ
BioLife Solutions Inc.
Electromedical & Electrotherapeutic Apparatus
$38.61
+3.51% 1D
Market Cap $1.8B
1M Return +8.67%
1Y Return +49.02%
Forward P/E 117.0x
Unified AI Score
46.0 / 100 HOLD
Tech 27.0 Fund 46.0 Flow 59.0 Mom 56.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FEMY +54.78% BLFS +49.02% Spread: +90.68 pp (FEMY Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period FEMY Revenue BLFS Revenue FEMY Op. Margin BLFS Op. Margin Margin Edge
FY2018 N/A $20M N/A 18.5% BLFS
FY2019 N/A $30M N/A -0.8% BLFS
FY2020 $0M $50M -668.0% -13.0% BLFS
FY2021 $0M $120M -706.7% -29.5% BLFS
FY2022 $0M $80M -961.7% -7.8% BLFS
FY2023 $0M $70M -1353.4% -25.3% BLFS
FY2024 $0M $70M -1091.8% -6.0% BLFS
FY2025 $0M $100M -767.0% -17.3% BLFS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FEMY (1) vs BLFS (9)
Institutional Metric FEMY BLFS Criterion Row Winner
Market Capitalization Scale $11.9M $1.8B Larger Scale BLFS
Trailing P/E Ratio Valuation N/M 37.3x Lower Multiple BLFS
Forward P/E Ratio Valuation N/M 117.0x Lower Multiple BLFS
Revenue Growth (YoY) Growth -18.9% +21.5% Higher Growth BLFS
Operating Margin (TTM) Profitability -763.9% 6.0% Higher Margin BLFS
Net Profit Margin Profitability 0.0% 54.4% Higher Margin BLFS
Return on Equity (ROE) Capital Efficiency -425.0% 12.8% Higher ROE BLFS
52-Week Range Position Momentum 17% ($0โ€“$6) 95% ($18โ€“$40) Stronger Trend BLFS
Beta / 30D Volatility Risk Regime 4.01ฮฒ ยท 72% Vol 1.05ฮฒ ยท 31% Vol Lower Realized Risk BLFS
Unified Institutional Score Composite Signal 52.6 / 100 (HOLD) 46.0 / 100 (HOLD) Higher Composite FEMY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FEMY vs BLFS Buy Guide
FEMY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FEMY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BLFS BREAKOUT
38d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live BLFS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FEMY nor BLFS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.